Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Court Weighs In On TÜV Rheinland PIP Case; Will It Vindicate The Notified Body?

Executive Summary

TÜV Rheinland has had a nightmare time in national courts on liability questions relating to its involvement with the notorious PIP breast implants. Will new European Court of Justice legal findings vindicate it sufficiently to persuade national courts? And what will this mean for notified bodies more generally?

You may also be interested in...



New PIP Court Ruling Sends Further Shockwaves Through EU Medtech Sector

Notified bodies in the EU medtech sector have reason to feel nervous: recipients of the fraudulently manufactured PIP breast implants have had yet more court success in a case that is challenging the liability status of notified bodies at a critical time for EU regulation. But the final say is still awaited.

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.

Second EU MDR Notified Body Designated In France

Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel